|
|
 |
|
Viewing report
|
|
|
|
Autoimmune Disease Therapeutics - Global Strategic Business Report
Global Industry Analysts, Inc., July 2009, Pages: 723
This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Billion by the following therapeutic class – Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Crohns Disease (Biologics only), and Others. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015.
The report profiles 115 companies including many key and niche players worldwide such as Abbott Laboratories, Amgen Inc., Bayer Schering Pharma AG, Biogen Idec Inc., Bristol-Myers Squibb Company, Elan Corporation, plc, Eli Lilly And Company, F. Hoffmann-La Roche AG, Chugai Pharmaceutical Co., Ltd., Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Inc., Merck Serono SA, Novartis AG, Sanofi-aventis SA , Schering-Plough Corporation, Shire Pharmaceuticals Group plc, Teva Pharmaceuticals Industries Limited, and UCB Pharma.
Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying
Customers who bought this item also bought
Autoimmune Disease Therapeutics
European Autoimmune Diseases Therapeutics Markets
What Strategies Will Yield Novel Treatments for Autoimmune Disease?
Autoimmune Disease Series: Systemic Sclerosis--Novel Treatment Approaches on the Horizon
Dealmaking and Industry Outlook: Autoimmune and Inflammatory Diseases
Therapeutic Proteins: Drugs, Devices, Distribution and Disease Therapeutics
Autoimmune and Inflammation - Transplant Rejection or Transplantation Drug Pipeline Report
Autoimmune/Inflammatory Disease: Competitive Strategies - Competitive Analysis, Profiles, and Portfolio Strategies of the Top Autoimmune/Inflammatory Therapeutic Manufacturers in the US (2001 Edition)
Immune Modulation Therapeutics
Autoimmune/Inflammatory Disease Drug Licensing Opportunities: Analysis, Rating and Ranking - A Worldwide Study
Drug Therapeutics: Therapeutic Proteins
Immune/Inflammatory Disease: Early-Stage R&D Technologies and Dealmaking
|
|
|
|
